Amedisys (NASDAQ:AMED) earlier ticked down 0.2% on a report that the Dept. of Justice has initially rejected the proposed ...

The U.S. Department of Justice (DOJ) has reportedly rejected Amedisys’ (Nasdaq: AMED) and UnitedHealth Group’s (NYSE: UNH) attempt to divest assets, a ...

Amedisys (NASDAQ:AMED) rose 1% in after hours trading after a divestiture agreement in its planned sale to UnitedHealth (NYSE ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the ...

UnitedHealth Group and Amedisys have found buyers for key divestitures aimed at getting their $3.3 billion merger over the ...

For those who have been following the U.S. Department of Justice’s (DOJ) legal battle against UnitedHealth Group (NYSE: UNH) ...

The companies said they have an agreement to sell home health and hospice locations to BrightSpring Health Services and The ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Amedisys shares have climbed 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $93.56, an increase of almost 3% in the last 12 months.

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the Department of Justice sued to block the deal last year. UnitedHealth’s ...

The sales are contingent on the closure of UnitedHealth’s acquisition of Amedisys, which has been held up after the Department of Justice sued to block the deal last year. Amedisys delivers ...